Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer

Autor:	Aredo, Jacqueline V., Wakelee, Heather A., Hui, Angela Bik-Yu, Padda, Sukhmani K., Joshi, Nitin D., Guo, H. Henry, Chaudhuri, Aadel, Diehn, Maximilian, Loo, Billy W., Jr., Neal, Joel W.
Zdroj:	In Cancer Treatment and Research Communications 2022 33
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect